CEO Saniona: »The real growth will come from our proprietary projects« 5 maj, 2020 Danish biotech Saniona recently presented positive topline results from a clinical phase II study in hypothalamic obesity (HO), one of several rare eating disorders and obesity related indications the company i... LÄS MER!
Exclusive BioStock Interview: Drug pricing debate looms large for life science investors 21 november, 2019 Claus Henrik Johansen, Senior Portfolio Manager Healthcare for Danske Bank Asset Management, sat down with BioStock to talk about the trends in the life science investment ecosystem. From his perspective, drug ... LÄS MER!
